Cohance Lifesciences Limited (COHANCE) Earnings Call Transcripts

23 earnings calls from October 2020 to August 5, 2026

NSEI IN Health Care Pharmaceuticals

About Cohance Lifesciences Limited

Cohance Lifesciences Limited (COHANCE) is a publicly listed company in the Pharmaceuticals industry, within the Health Care sector. It trades on NSEI and is based in IN. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 23 calls on record spanning October 31, 2020 to August 5, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.

Earnings Call History

EarningsCalls.dev has 23 Cohance Lifesciences Limited earnings call transcripts on record, spanning October 31, 2020 to August 5, 2026. Based on this history, Cohance Lifesciences Limited reports quarterly. The most recent call on file is dated August 5, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker
COHANCE
Exchange
NSEI
Country
IN
Sector
Health Care
Industry
Pharmaceuticals
Calls on record
23
First call
October 31, 2020
Most recent
August 5, 2026
Reporting cadence
quarterly
Quarter Date
Q1 FY2027 Aug 5, 2026 Read transcript
Q4 FY2026 May 12, 2026 Read transcript
Q3 FY2026 Feb 12, 2026 Read transcript
Shareholder/Analyst Calls Oct 28, 2025 Read transcript
Q4 FY2025 May 28, 2025 Read transcript
Q3 FY2025 Feb 12, 2025 Read transcript
M&A Calls Dec 9, 2024 Read transcript
Q2 FY2025 Nov 12, 2024 Read transcript
Q4 FY2024 May 30, 2024 Read transcript
M&A Calls Mar 5, 2024 Read transcript
Q3 FY2024 Feb 5, 2024 Read transcript
Q2 FY2024 Nov 9, 2023 Read transcript
Q1 FY2024 Aug 10, 2023 Read transcript
Q4 FY2023 May 26, 2023 Read transcript
Q3 FY2023 Feb 7, 2023 Read transcript
Q2 FY2023 Nov 9, 2022 Read transcript
Q1 FY2023 Aug 8, 2022 Read transcript
Q4 FY2022 May 10, 2022 Read transcript
Q3 FY2022 Feb 9, 2022 Read transcript
Q2 FY2022 Nov 8, 2021 Read transcript
Q4 FY2021 Jun 9, 2021 Read transcript
Q3 FY2021 Feb 11, 2021 Read transcript
Q2 FY2021 Oct 31, 2020 Read transcript